⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

May 1, 2024HeliyonOpen Access

Astragaloside IV inhibits angiotensin II-induced atrial fibrosis and atrial fibrillation by SIRT1/PGC-1α/FNDC5 pathway

Xinpeng Cong Xi Zhu Xiaogang Zhang Zhongping Ning

View Full Paper

Ask AI

Bookmark

Share

Abstract

Astragaloside IV (AS-IV) has been found to possess anti-oxidative, anti-inflammatory, and anti-apoptotic properties, but its effect on atrial fibrosis is yet to be determined. This research investigates the protective role of AS-IV in angiotensin II (Ang II)-induced atrial fibrosis and atrial fibrillation (AF).

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Cong et al. (2024) studied this question.

synapsesocial.com/papers/68e6c333b6db643587642310 https://doi.org/10.1016/j.heliyon.2024.e30984

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Anti-fibrosis effect of astragaloside IV in animal models of cardiovascular diseases and its mechanisms: a systematic reviewsystematic_review · 2025 · 9 citations
2Astragaloside IV attenuate MI-induced myocardial fibrosis and cardiac remodeling by inhibiting ROS/caspase-1/GSDMD signaling pathwaypreclinical · 2022 · 122 citations
3The interventional effect of astragaloside IV on rodent models of myocardial fibrosis: a systematic review and meta-analysis2025 · 1 citations
4Astragaloside IV attenuates high-glucose-Induced peritoneal fibrosis via modulation of the ENKUR/PI3K/Akt signalling pathwayIn Vitro Study · 2026 · 2 citations
5Inhibition of cardiotrophin-1 overexpression is involved in the anti-fibrotic effect of Astrogaloside IVpreclinical · 2017 · 18 citations

More related papers

Astragaloside IV inhibits isoprenaline-induced cardiac fibrosis by targeting the reactive oxygen species/mitogen-activated protein kinase signaling axis2017
Integrative transcriptomics and proteomics analysis reveal the protection of Astragaloside IV against myocardial fibrosis by regulating senescence2024
Therapeutic effects and potential mechanisms of astragaloside IV on pulmonary fibrosis: a systematic review and meta-analysis of preclinical studies2025

More from Heliyon

Multi-omics profiling of esophagus basaloid squamous cell carcinoma reveals potential signatures for diagnosis and therapeuticsFri,
Normative values of ventricular indices of brain using computed tomography scans in Bangladeshi adults: a cross-sectional studyFri,